THAÇI, D.; ARMSTRONG, A.; LEBWOHL, M.; BLAUVELT, A.; PAUL, C.; PUIG, L.; WANG, M.; VANVOORDEN, V.; MADDEN, C.; WIEGRATZ, S.; DEHERDER, D.; GORDON, K. Maintenance of bimekizumab efficacy through 2 years in patients with moderate to severe plaque psoriasis: Pooled results from five phase 3/3b trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 6, p. s71, 2022. DOI: 10.25251/skin.6.supp.71. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1827. Acesso em: 3 jul. 2024.